Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Tal Zaks, chief medical officer of Moderna, tells "Axios on HBO" that a COVID-19 vaccine could be available for children by the middle of next year.
Be smart: There will be a coronavirus vaccine for adults long before there is one for kids.
- Moderna hasn't yet begun testing with anyone under 18 years-old, while Pfizer just recently began with teenagers.
- Clinical trials for younger populations should move faster than did clinical trials for adults, because the vaccine-makers will begin with much more human data.
- Zaks also warns not to "overinterpret the results" so far on efficacy, in that they only relate to protecting someone against getting sick, not against transmitting the virus to others.
The bottom line: Schools may not be able to fully reopen by late spring, even if all adult staff are vaccinated.